ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003

ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003

Abstract Background ND630 is believed to be a new therapy pharmacologic molecule in targeting the expression of ACACA and regulating the lipid metabolism. However, the function of ND630 in prostate cancer remains unknown. KIF18B, as an oncogene, plays a vital role in prostate cancer progression. cir...

Full description

Bibliographic Details
Main Authors: Yu-Peng Wu, Wen-Cai Zheng, Qi Huang, Xu-Yun Huang, Fei Lin, Zhi-Bin Ke, Qi You, Qing-Shui Zheng, Yong Wei, Xue-Yi Xue, Ning Xu
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Journal of Translational Medicine
Subjects:
CircRNAs
Prostate cancer
ACACA
ND630
Online Access:https://doi.org/10.1186/s12967-023-04760-w

Similar Items

Similar Items